

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.79795122 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.99805041 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.74620796 |
| 4 | * synaptic transmission, dopaminergic (GO:0001963) | 5.70862520 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.67870518 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.59552234 |
| 7 | * prepulse inhibition (GO:0060134) | 5.50488289 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47547222 |
| 9 | locomotory exploration behavior (GO:0035641) | 5.36481807 |
| 10 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.24092564 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.18479367 |
| 12 | vocalization behavior (GO:0071625) | 5.13092382 |
| 13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.07863517 |
| 14 | neurofilament cytoskeleton organization (GO:0060052) | 5.05447986 |
| 15 | presynaptic membrane organization (GO:0097090) | 5.03917756 |
| 16 | cell migration in hindbrain (GO:0021535) | 4.98035614 |
| 17 | adenosine receptor signaling pathway (GO:0001973) | 4.98019053 |
| 18 | * regulation of synapse structural plasticity (GO:0051823) | 4.78054165 |
| 19 | neuromuscular synaptic transmission (GO:0007274) | 4.77472455 |
| 20 | * response to amphetamine (GO:0001975) | 4.77363618 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.75145925 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.54423133 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.54243578 |
| 24 | mating behavior (GO:0007617) | 4.53437404 |
| 25 | nucleobase catabolic process (GO:0046113) | 4.52210061 |
| 26 | axonal fasciculation (GO:0007413) | 4.49074237 |
| 27 | neuron recognition (GO:0008038) | 4.48388741 |
| 28 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.45614298 |
| 29 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.45191221 |
| 30 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43181449 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.40470374 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.38300851 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.31618237 |
| 34 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.31312682 |
| 35 | cAMP catabolic process (GO:0006198) | 4.28312668 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.26858339 |
| 37 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.22104003 |
| 38 | * dopamine receptor signaling pathway (GO:0007212) | 4.21689622 |
| 39 | glutamate secretion (GO:0014047) | 4.20352997 |
| 40 | regulation of dopamine metabolic process (GO:0042053) | 4.10930823 |
| 41 | regulation of catecholamine metabolic process (GO:0042069) | 4.10930823 |
| 42 | ganglion development (GO:0061548) | 4.09781932 |
| 43 | neuromuscular process controlling balance (GO:0050885) | 4.09677982 |
| 44 | * striatum development (GO:0021756) | 4.09057732 |
| 45 | mitochondrion transport along microtubule (GO:0047497) | 4.05490994 |
| 46 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.05490994 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 4.03004625 |
| 48 | peripheral nervous system neuron development (GO:0048935) | 3.99233722 |
| 49 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.98529984 |
| 50 | exploration behavior (GO:0035640) | 3.97457598 |
| 51 | protein localization to synapse (GO:0035418) | 3.97054458 |
| 52 | presynaptic membrane assembly (GO:0097105) | 3.96970988 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96395316 |
| 54 | regulation of protein kinase A signaling (GO:0010738) | 3.93654862 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.92482127 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 3.91521271 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.91505340 |
| 58 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91232611 |
| 59 | * neuron-neuron synaptic transmission (GO:0007270) | 3.90884323 |
| 60 | regulation of glutamate secretion (GO:0014048) | 3.89225631 |
| 61 | activation of protein kinase A activity (GO:0034199) | 3.86520058 |
| 62 | layer formation in cerebral cortex (GO:0021819) | 3.85693235 |
| 63 | neuron cell-cell adhesion (GO:0007158) | 3.85111289 |
| 64 | membrane hyperpolarization (GO:0060081) | 3.83653594 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.81078829 |
| 66 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.79152443 |
| 67 | cyclic nucleotide catabolic process (GO:0009214) | 3.77073112 |
| 68 | synaptic transmission, cholinergic (GO:0007271) | 3.75402174 |
| 69 | neuronal ion channel clustering (GO:0045161) | 3.74969073 |
| 70 | regulation of female receptivity (GO:0045924) | 3.73813281 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 3.73754302 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.72093464 |
| 73 | regulation of postsynaptic membrane potential (GO:0060078) | 3.69831144 |
| 74 | synaptic transmission, glutamatergic (GO:0035249) | 3.67836024 |
| 75 | neurotransmitter transport (GO:0006836) | 3.66566745 |
| 76 | neuronal action potential propagation (GO:0019227) | 3.64043367 |
| 77 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.63429718 |
| 78 | * positive regulation of neurotransmitter transport (GO:0051590) | 3.61662374 |
| 79 | dendrite morphogenesis (GO:0048813) | 3.56712509 |
| 80 | * behavioral response to cocaine (GO:0048148) | 3.55785021 |
| 81 | neuron maturation (GO:0042551) | 3.54024136 |
| 82 | cAMP metabolic process (GO:0046058) | 3.51839721 |
| 83 | glutamate receptor signaling pathway (GO:0007215) | 3.50361636 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 3.49076803 |
| 85 | long-term synaptic potentiation (GO:0060291) | 3.47408467 |
| 86 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44154723 |
| 87 | sympathetic nervous system development (GO:0048485) | 3.43834933 |
| 88 | * regulation of synaptic plasticity (GO:0048167) | 3.42888695 |
| 89 | behavioral defense response (GO:0002209) | 3.42765667 |
| 90 | behavioral fear response (GO:0001662) | 3.42765667 |
| 91 | * negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.41725374 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.38929965 |
| 93 | glycine transport (GO:0015816) | 3.38749112 |
| 94 | neurotransmitter catabolic process (GO:0042135) | 3.37586923 |
| 95 | cerebellar granule cell differentiation (GO:0021707) | 3.35967737 |
| 96 | postsynaptic membrane organization (GO:0001941) | 3.34661488 |
| 97 | female mating behavior (GO:0060180) | 3.34334435 |
| 98 | regulation of vesicle fusion (GO:0031338) | 3.33760960 |
| 99 | * long-term memory (GO:0007616) | 3.33419037 |
| 100 | * response to amine (GO:0014075) | 3.32403655 |
| 101 | membrane depolarization (GO:0051899) | 3.31711228 |
| 102 | negative regulation of dendrite development (GO:2000171) | 3.31075250 |
| 103 | * visual learning (GO:0008542) | 3.30019039 |
| 104 | cell differentiation in hindbrain (GO:0021533) | 3.29414729 |
| 105 | cranial nerve development (GO:0021545) | 3.29291129 |
| 106 | serotonin metabolic process (GO:0042428) | 3.29024570 |
| 107 | neuromuscular process controlling posture (GO:0050884) | 3.26548826 |
| 108 | positive regulation of synapse maturation (GO:0090129) | 3.26234500 |
| 109 | catecholamine transport (GO:0051937) | 3.25386060 |
| 110 | retinal ganglion cell axon guidance (GO:0031290) | 3.25071921 |
| 111 | regulation of dendritic spine development (GO:0060998) | 3.24911652 |
| 112 | drinking behavior (GO:0042756) | 3.23902173 |
| 113 | positive regulation of gastrulation (GO:2000543) | 3.22612965 |
| 114 | left/right pattern formation (GO:0060972) | 3.22239033 |
| 115 | dopamine transport (GO:0015872) | 3.22218970 |
| 116 | * regulation of neurotransmitter transport (GO:0051588) | 3.22111367 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 3.21076111 |
| 118 | * synapse assembly (GO:0007416) | 3.20618142 |
| 119 | urinary tract smooth muscle contraction (GO:0014848) | 3.18860097 |
| 120 | cGMP metabolic process (GO:0046068) | 3.17825186 |
| 121 | cellular response to nicotine (GO:0071316) | 3.17152780 |
| 122 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.16572344 |
| 123 | * visual behavior (GO:0007632) | 3.15751680 |
| 124 | regulation of norepinephrine secretion (GO:0014061) | 3.15142912 |
| 125 | fear response (GO:0042596) | 3.14057503 |
| 126 | cAMP biosynthetic process (GO:0006171) | 3.13835541 |
| 127 | * learning (GO:0007612) | 3.12925923 |
| 128 | neuron remodeling (GO:0016322) | 3.12382902 |
| 129 | epithelial cilium movement (GO:0003351) | 3.08517529 |
| 130 | detection of temperature stimulus (GO:0016048) | 3.08153837 |
| 131 | neuromuscular process (GO:0050905) | 3.07927977 |
| 132 | spinal cord association neuron differentiation (GO:0021527) | 3.07065332 |
| 133 | regulation of membrane repolarization (GO:0060306) | 3.06595616 |
| 134 | positive regulation of dendritic spine development (GO:0060999) | 3.06478429 |
| 135 | body morphogenesis (GO:0010171) | 3.03697594 |
| 136 | negative regulation of microtubule polymerization (GO:0031115) | 3.02762283 |
| 137 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02369666 |
| 138 | positive regulation of synapse assembly (GO:0051965) | 3.02266172 |
| 139 | phenol-containing compound catabolic process (GO:0019336) | 3.00680711 |
| 140 | catecholamine biosynthetic process (GO:0042423) | 3.00327872 |
| 141 | catechol-containing compound biosynthetic process (GO:0009713) | 3.00327872 |
| 142 | norepinephrine metabolic process (GO:0042415) | 2.97584275 |
| 143 | protein localization to microtubule (GO:0035372) | 2.95195558 |
| 144 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.94890701 |
| 145 | innervation (GO:0060384) | 2.93453427 |
| 146 | forebrain neuron differentiation (GO:0021879) | 2.93400344 |
| 147 | axon extension (GO:0048675) | 2.88469783 |
| 148 | cranial nerve morphogenesis (GO:0021602) | 2.87912960 |
| 149 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83817191 |
| 150 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.79287325 |
| 151 | * neuron migration (GO:0001764) | 2.79184881 |
| 152 | central nervous system myelination (GO:0022010) | 2.78219681 |
| 153 | axon ensheathment in central nervous system (GO:0032291) | 2.78219681 |
| 154 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.77785138 |
| 155 | * adult walking behavior (GO:0007628) | 2.77579974 |
| 156 | * synapse organization (GO:0050808) | 2.77145801 |
| 157 | * substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.76948816 |
| 158 | * substrate-independent telencephalic tangential migration (GO:0021826) | 2.76948816 |
| 159 | paraxial mesoderm development (GO:0048339) | 2.75277395 |
| 160 | embryonic body morphogenesis (GO:0010172) | 2.73410881 |
| 161 | negative regulation of neurotransmitter transport (GO:0051589) | 2.73378168 |
| 162 | regulation of axonogenesis (GO:0050770) | 2.72994111 |
| 163 | * response to nicotine (GO:0035094) | 2.72227570 |
| 164 | membrane repolarization (GO:0086009) | 2.71676599 |
| 165 | membrane repolarization during action potential (GO:0086011) | 2.70232799 |
| 166 | regulation of glucocorticoid secretion (GO:2000849) | 2.68395792 |
| 167 | * positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.68008913 |
| 168 | short-term memory (GO:0007614) | 2.67421256 |
| 169 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.66258220 |
| 170 | negative regulation of axonogenesis (GO:0050771) | 2.65407861 |
| 171 | axon extension involved in axon guidance (GO:0048846) | 2.62507122 |
| 172 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.62507122 |
| 173 | cilium movement (GO:0003341) | 2.61049781 |
| 174 | dopamine biosynthetic process (GO:0042416) | 2.59283431 |
| 175 | spinal cord development (GO:0021510) | 2.56468069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.77545788 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.86451722 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12993456 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12801082 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12442869 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.92474892 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90721606 |
| 8 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.80531354 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71956093 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71956093 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70766675 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69637829 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.65766022 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63244531 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60561128 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55800089 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55693756 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46505148 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42229622 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.39757353 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39542450 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.28769740 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28733003 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.28077063 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25136187 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22185656 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13198742 |
| 28 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.08277497 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06635332 |
| 30 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.98010115 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95002526 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90763428 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86754927 |
| 34 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.86058217 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.84806032 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83235125 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80022779 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79191334 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76790616 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57939696 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49016407 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48714234 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46781644 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45991112 |
| 45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.42305357 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40690893 |
| 47 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38899158 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36348492 |
| 49 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34426882 |
| 50 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.33058685 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32268206 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30355854 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30080362 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29936955 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28678782 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27781225 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27321492 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27145854 |
| 59 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25729146 |
| 60 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20479706 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20256136 |
| 62 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19949000 |
| 63 | * AR_19668381_ChIP-Seq_PC3_Human | 1.19300920 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18321700 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17978716 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17182074 |
| 67 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.14355727 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12558854 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12305318 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12214030 |
| 71 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.12030837 |
| 72 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.06387470 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05466440 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05466440 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05057888 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04491639 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04435195 |
| 78 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03715778 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02802545 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02050761 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01969422 |
| 82 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00836495 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00640163 |
| 84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00041599 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99862495 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98966864 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97800899 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95083759 |
| 89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94781116 |
| 90 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94345874 |
| 91 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94144944 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93538723 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92607788 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92604951 |
| 95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92285982 |
| 96 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91703269 |
| 97 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91347839 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91032056 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90584347 |
| 100 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90562961 |
| 101 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90544029 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90531077 |
| 103 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89679774 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89347340 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89325169 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89082194 |
| 107 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88923620 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88841954 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88726228 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87946403 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87871210 |
| 112 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87404083 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87296409 |
| 114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86817788 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86351475 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86229068 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86129951 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86114572 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86050059 |
| 120 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.83869817 |
| 121 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83786211 |
| 122 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83022196 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82269846 |
| 124 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.77560749 |
| 125 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.77028917 |
| 126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76361791 |
| 127 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.74616282 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73290205 |
| 129 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.72198976 |
| 130 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.72143651 |
| 131 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.71067056 |
| 132 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.70768137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002822_catalepsy | 6.71714030 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.21796415 |
| 3 | MP0003880_abnormal_central_pattern | 5.04731646 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.18267195 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.71017625 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.41624537 |
| 7 | MP0004270_analgesia | 3.19655717 |
| 8 | * MP0002064_seizures | 3.12619293 |
| 9 | MP0009046_muscle_twitch | 3.12360177 |
| 10 | MP0001984_abnormal_olfaction | 2.95080309 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.89759365 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.82840441 |
| 13 | * MP0001486_abnormal_startle_reflex | 2.70005673 |
| 14 | * MP0002272_abnormal_nervous_system | 2.53271454 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.41236178 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.32805511 |
| 17 | * MP0001529_abnormal_vocalization | 2.31448589 |
| 18 | MP0003123_paternal_imprinting | 2.25382494 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.23403885 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.20176797 |
| 21 | * MP0005386_behavior/neurological_phenoty | 2.06739043 |
| 22 | * MP0004924_abnormal_behavior | 2.06739043 |
| 23 | MP0008789_abnormal_olfactory_epithelium | 2.05455108 |
| 24 | MP0000537_abnormal_urethra_morphology | 1.99210711 |
| 25 | MP0001970_abnormal_pain_threshold | 1.93532061 |
| 26 | MP0009053_abnormal_anal_canal | 1.91634166 |
| 27 | MP0002751_abnormal_autonomic_nervous | 1.89228861 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.89061469 |
| 29 | * MP0002909_abnormal_adrenal_gland | 1.82119393 |
| 30 | * MP0001905_abnormal_dopamine_level | 1.81285535 |
| 31 | MP0008569_lethality_at_weaning | 1.80256824 |
| 32 | * MP0004811_abnormal_neuron_physiology | 1.75140303 |
| 33 | * MP0002557_abnormal_social/conspecific_i | 1.73846734 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.65954551 |
| 35 | MP0008872_abnormal_physiological_respon | 1.65803661 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.65310736 |
| 37 | MP0003315_abnormal_perineum_morphology | 1.60710313 |
| 38 | MP0002090_abnormal_vision | 1.57667347 |
| 39 | MP0002184_abnormal_innervation | 1.54154660 |
| 40 | MP0002736_abnormal_nociception_after | 1.51321613 |
| 41 | MP0005187_abnormal_penis_morphology | 1.49094725 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.48479698 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.46007602 |
| 44 | MP0002102_abnormal_ear_morphology | 1.45058050 |
| 45 | MP0000538_abnormal_urinary_bladder | 1.43722539 |
| 46 | MP0003879_abnormal_hair_cell | 1.40675923 |
| 47 | MP0003633_abnormal_nervous_system | 1.40546186 |
| 48 | MP0003121_genomic_imprinting | 1.39538622 |
| 49 | * MP0002066_abnormal_motor_capabilities/c | 1.38218656 |
| 50 | MP0001177_atelectasis | 1.34745416 |
| 51 | MP0003890_abnormal_embryonic-extraembry | 1.33667418 |
| 52 | * MP0003861_abnormal_nervous_system | 1.32429318 |
| 53 | MP0000955_abnormal_spinal_cord | 1.32415030 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.31777584 |
| 55 | * MP0002882_abnormal_neuron_morphology | 1.27918743 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.25954789 |
| 57 | MP0002928_abnormal_bile_duct | 1.25720102 |
| 58 | MP0003075_altered_response_to | 1.25550275 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.25430692 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.25060344 |
| 61 | MP0003878_abnormal_ear_physiology | 1.25060344 |
| 62 | MP0004885_abnormal_endolymph | 1.24596911 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.23304502 |
| 64 | MP0003119_abnormal_digestive_system | 1.21196417 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.21011367 |
| 66 | * MP0008874_decreased_physiological_sensi | 1.20504920 |
| 67 | MP0005499_abnormal_olfactory_system | 1.19130173 |
| 68 | MP0005394_taste/olfaction_phenotype | 1.19130173 |
| 69 | MP0000566_synostosis | 1.18310420 |
| 70 | MP0003329_amyloid_beta_deposits | 1.17688766 |
| 71 | MP0003942_abnormal_urinary_system | 1.17567492 |
| 72 | MP0005670_abnormal_white_adipose | 1.12912021 |
| 73 | MP0003631_nervous_system_phenotype | 1.11742817 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 1.11725949 |
| 75 | MP0004142_abnormal_muscle_tone | 1.11441230 |
| 76 | MP0000778_abnormal_nervous_system | 1.09721066 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.08462690 |
| 78 | MP0002163_abnormal_gland_morphology | 1.03242023 |
| 79 | * MP0005646_abnormal_pituitary_gland | 1.02946992 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.02849019 |
| 81 | MP0003690_abnormal_glial_cell | 1.02820727 |
| 82 | MP0004858_abnormal_nervous_system | 1.01484662 |
| 83 | MP0006292_abnormal_olfactory_placode | 1.00312235 |
| 84 | MP0000751_myopathy | 1.00221039 |
| 85 | * MP0004085_abnormal_heartbeat | 0.99856276 |
| 86 | MP0002229_neurodegeneration | 0.99826034 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.99154840 |
| 88 | MP0003283_abnormal_digestive_organ | 0.98843980 |
| 89 | * MP0002069_abnormal_eating/drinking_beha | 0.95932832 |
| 90 | * MP0002152_abnormal_brain_morphology | 0.95604411 |
| 91 | MP0002160_abnormal_reproductive_system | 0.94590848 |
| 92 | * MP0005535_abnormal_body_temperature | 0.93632218 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.92844718 |
| 94 | MP0000026_abnormal_inner_ear | 0.88516000 |
| 95 | MP0000516_abnormal_urinary_system | 0.88264662 |
| 96 | MP0005367_renal/urinary_system_phenotyp | 0.88264662 |
| 97 | MP0004133_heterotaxia | 0.86739999 |
| 98 | MP0003787_abnormal_imprinting | 0.86608013 |
| 99 | MP0000920_abnormal_myelination | 0.86192140 |
| 100 | MP0002697_abnormal_eye_size | 0.86083469 |
| 101 | MP0003011_delayed_dark_adaptation | 0.84193627 |
| 102 | MP0005645_abnormal_hypothalamus_physiol | 0.82694684 |
| 103 | MP0003385_abnormal_body_wall | 0.82478247 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.82063732 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.80496232 |
| 106 | MP0002233_abnormal_nose_morphology | 0.80129235 |
| 107 | MP0003634_abnormal_glial_cell | 0.79623557 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.79266860 |
| 109 | MP0002081_perinatal_lethality | 0.79072486 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.77114066 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 0.75533048 |
| 112 | MP0003937_abnormal_limbs/digits/tail_de | 0.75435158 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.75277562 |
| 114 | MP0001286_abnormal_eye_development | 0.73580152 |
| 115 | * MP0001188_hyperpigmentation | 0.73391314 |
| 116 | MP0003122_maternal_imprinting | 0.73222346 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.73028850 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70852167 |
| 119 | MP0003948_abnormal_gas_homeostasis | 0.70174323 |
| 120 | MP0005195_abnormal_posterior_eye | 0.69913366 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.66593048 |
| 122 | MP0004742_abnormal_vestibular_system | 0.64797943 |
| 123 | MP0003632_abnormal_nervous_system | 0.64085864 |
| 124 | * MP0000631_abnormal_neuroendocrine_gland | 0.62104743 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.59841838 |
| 126 | MP0004233_abnormal_muscle_weight | 0.57667017 |
| 127 | MP0004043_abnormal_pH_regulation | 0.56010281 |
| 128 | MP0000534_abnormal_ureter_morphology | 0.55999422 |
| 129 | * MP0001943_abnormal_respiration | 0.52796640 |
| 130 | MP0001485_abnormal_pinna_reflex | 0.51406494 |
| 131 | * MP0003956_abnormal_body_size | 0.51033876 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.50900974 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.48618463 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.48230705 |
| 135 | MP0005620_abnormal_muscle_contractility | 0.47735351 |
| 136 | MP0005166_decreased_susceptibility_to | 0.47036681 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.46449976 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.46327790 |
| 139 | MP0000747_muscle_weakness | 0.46212855 |
| 140 | * MP0010769_abnormal_survival | 0.45952465 |
| 141 | * MP0001664_abnormal_digestion | 0.45925492 |
| 142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44895994 |
| 143 | * MP0010770_preweaning_lethality | 0.44757747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.39905836 |
| 2 | Focal motor seizures (HP:0011153) | 7.02970947 |
| 3 | Limb dystonia (HP:0002451) | 5.65133068 |
| 4 | Focal seizures (HP:0007359) | 5.64599744 |
| 5 | Neonatal hypoglycemia (HP:0001998) | 4.72455434 |
| 6 | Visual hallucinations (HP:0002367) | 4.46156552 |
| 7 | Resting tremor (HP:0002322) | 4.34819970 |
| 8 | Action tremor (HP:0002345) | 4.10336069 |
| 9 | Ankle clonus (HP:0011448) | 4.08715183 |
| 10 | Hepatoblastoma (HP:0002884) | 4.01195573 |
| 11 | Poor eye contact (HP:0000817) | 3.73055860 |
| 12 | Annular pancreas (HP:0001734) | 3.70631138 |
| 13 | Abnormal pancreas size (HP:0012094) | 3.67462580 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.63156414 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.60610921 |
| 16 | Febrile seizures (HP:0002373) | 3.57546815 |
| 17 | Absence seizures (HP:0002121) | 3.57423494 |
| 18 | * Torticollis (HP:0000473) | 3.56379303 |
| 19 | Impaired social interactions (HP:0000735) | 3.45194386 |
| 20 | Abnormal social behavior (HP:0012433) | 3.45194386 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.42401384 |
| 22 | Prolonged QT interval (HP:0001657) | 3.42191509 |
| 23 | * Anxiety (HP:0000739) | 3.34616144 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.33459762 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.32371889 |
| 26 | Broad-based gait (HP:0002136) | 3.31830453 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.29120950 |
| 28 | Dialeptic seizures (HP:0011146) | 3.23683972 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 3.23514588 |
| 30 | Rib fusion (HP:0000902) | 3.15326231 |
| 31 | Limb hypertonia (HP:0002509) | 3.13460483 |
| 32 | Ankyloglossia (HP:0010296) | 3.10628027 |
| 33 | Postural instability (HP:0002172) | 3.10181584 |
| 34 | * Focal dystonia (HP:0004373) | 3.01526562 |
| 35 | * Depression (HP:0000716) | 2.99767465 |
| 36 | Abnormal EKG (HP:0003115) | 2.97851590 |
| 37 | * Craniofacial dystonia (HP:0012179) | 2.97202787 |
| 38 | Urinary urgency (HP:0000012) | 2.94928452 |
| 39 | Truncal ataxia (HP:0002078) | 2.93935935 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.93250317 |
| 41 | Dysmetria (HP:0001310) | 2.91327706 |
| 42 | Atonic seizures (HP:0010819) | 2.86973931 |
| 43 | Papilledema (HP:0001085) | 2.86966650 |
| 44 | Stereotypic behavior (HP:0000733) | 2.83006471 |
| 45 | Dysmetric saccades (HP:0000641) | 2.80492445 |
| 46 | Scanning speech (HP:0002168) | 2.79555418 |
| 47 | Lower limb amyotrophy (HP:0007210) | 2.78994063 |
| 48 | Anomalous pulmonary venous return (HP:0010772) | 2.78508047 |
| 49 | Spastic gait (HP:0002064) | 2.76780494 |
| 50 | Abnormality of the intervertebral disk (HP:0005108) | 2.75728169 |
| 51 | Pointed chin (HP:0000307) | 2.74039940 |
| 52 | Bradykinesia (HP:0002067) | 2.73781028 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.72589396 |
| 54 | Pheochromocytoma (HP:0002666) | 2.66682880 |
| 55 | Atrioventricular block (HP:0001678) | 2.63595954 |
| 56 | Short 4th metacarpal (HP:0010044) | 2.61180394 |
| 57 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.61180394 |
| 58 | Hypothermia (HP:0002045) | 2.59947693 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.59305822 |
| 60 | Oligodactyly (hands) (HP:0001180) | 2.58505550 |
| 61 | Mutism (HP:0002300) | 2.53635431 |
| 62 | Gait imbalance (HP:0002141) | 2.49208548 |
| 63 | Intention tremor (HP:0002080) | 2.47945714 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.46913370 |
| 65 | Drooling (HP:0002307) | 2.45925775 |
| 66 | Ventricular fibrillation (HP:0001663) | 2.45757760 |
| 67 | Agitation (HP:0000713) | 2.44817140 |
| 68 | Polygenic inheritance (HP:0010982) | 2.44014881 |
| 69 | Adrenal hypoplasia (HP:0000835) | 2.41522505 |
| 70 | Clonus (HP:0002169) | 2.41009077 |
| 71 | Anosmia (HP:0000458) | 2.38852561 |
| 72 | Progressive inability to walk (HP:0002505) | 2.37702081 |
| 73 | Abnormality of the pulmonary veins (HP:0011718) | 2.36836802 |
| 74 | Orthostatic hypotension (HP:0001278) | 2.34753314 |
| 75 | Megalencephaly (HP:0001355) | 2.34147491 |
| 76 | Self-mutilation (HP:0000742) | 2.33382938 |
| 77 | Central scotoma (HP:0000603) | 2.32831760 |
| 78 | Impaired vibratory sensation (HP:0002495) | 2.29760972 |
| 79 | Neuroendocrine neoplasm (HP:0100634) | 2.29494748 |
| 80 | Rigidity (HP:0002063) | 2.27617565 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27113614 |
| 82 | Abnormality of oral frenula (HP:0000190) | 2.25141353 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.24866232 |
| 84 | Amblyopia (HP:0000646) | 2.23746294 |
| 85 | Excessive salivation (HP:0003781) | 2.20172622 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.19266101 |
| 87 | Vaginal atresia (HP:0000148) | 2.19111003 |
| 88 | Cortical dysplasia (HP:0002539) | 2.16155358 |
| 89 | Heart block (HP:0012722) | 2.15587457 |
| 90 | Upper limb amyotrophy (HP:0009129) | 2.13342583 |
| 91 | Distal upper limb amyotrophy (HP:0007149) | 2.13342583 |
| 92 | Hypoplasia of the brainstem (HP:0002365) | 2.13093224 |
| 93 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.13093224 |
| 94 | Primary atrial arrhythmia (HP:0001692) | 2.11720177 |
| 95 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.11685124 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11638884 |
| 97 | Genetic anticipation (HP:0003743) | 2.11017545 |
| 98 | Anencephaly (HP:0002323) | 2.10340210 |
| 99 | Insidious onset (HP:0003587) | 2.08837030 |
| 100 | Termporal pattern (HP:0011008) | 2.08837030 |
| 101 | Renal hypoplasia (HP:0000089) | 2.08384922 |
| 102 | Abnormality of the 4th metacarpal (HP:0010012) | 2.07298405 |
| 103 | Genital tract atresia (HP:0001827) | 2.06479398 |
| 104 | Atrial fibrillation (HP:0005110) | 2.06095496 |
| 105 | Cerebral inclusion bodies (HP:0100314) | 2.05030058 |
| 106 | Abnormality of the corticospinal tract (HP:0002492) | 2.03849176 |
| 107 | Hemiparesis (HP:0001269) | 2.03634513 |
| 108 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02329695 |
| 109 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00541529 |
| 110 | Neurofibrillary tangles (HP:0002185) | 1.99525966 |
| 111 | Supraventricular tachycardia (HP:0004755) | 1.99425618 |
| 112 | Diastasis recti (HP:0001540) | 1.99421938 |
| 113 | Status epilepticus (HP:0002133) | 1.99356514 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 1.98988994 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 1.98727382 |
| 116 | Polyphagia (HP:0002591) | 1.98209018 |
| 117 | Congenital primary aphakia (HP:0007707) | 1.97333577 |
| 118 | Hemiplegia (HP:0002301) | 1.97059346 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 1.96308700 |
| 120 | Growth hormone deficiency (HP:0000824) | 1.95431749 |
| 121 | Congenital stationary night blindness (HP:0007642) | 1.95203379 |
| 122 | Poor suck (HP:0002033) | 1.94794538 |
| 123 | Labial hypoplasia (HP:0000066) | 1.93894744 |
| 124 | Aqueductal stenosis (HP:0002410) | 1.93647843 |
| 125 | Abnormal atrioventricular conduction (HP:0005150) | 1.93503276 |
| 126 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93108734 |
| 127 | Dysphonia (HP:0001618) | 1.93022880 |
| 128 | Medial flaring of the eyebrow (HP:0010747) | 1.92803394 |
| 129 | Cutaneous finger syndactyly (HP:0010554) | 1.92674074 |
| 130 | Hyperventilation (HP:0002883) | 1.92566166 |
| 131 | Oligodactyly (HP:0012165) | 1.92553377 |
| 132 | Truncus arteriosus (HP:0001660) | 1.92360325 |
| 133 | Abnormality of the aortic arch (HP:0012303) | 1.91746383 |
| 134 | Supraventricular arrhythmia (HP:0005115) | 1.91679265 |
| 135 | Failure to thrive in infancy (HP:0001531) | 1.91580376 |
| 136 | Muscular hypotonia of the trunk (HP:0008936) | 1.89857294 |
| 137 | Abnormality of saccadic eye movements (HP:0000570) | 1.89169744 |
| 138 | Hypoventilation (HP:0002791) | 1.88603343 |
| 139 | Postural tremor (HP:0002174) | 1.87960761 |
| 140 | Neoplasm of the adrenal cortex (HP:0100641) | 1.87705591 |
| 141 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87051388 |
| 142 | Hypsarrhythmia (HP:0002521) | 1.86937734 |
| 143 | Hemivertebrae (HP:0002937) | 1.85334276 |
| 144 | Bowel incontinence (HP:0002607) | 1.85286901 |
| 145 | * Incomplete penetrance (HP:0003829) | 1.83816337 |
| 146 | Bicornuate uterus (HP:0000813) | 1.83242507 |
| 147 | Retinal dysplasia (HP:0007973) | 1.82329263 |
| 148 | Overgrowth (HP:0001548) | 1.81850077 |
| 149 | Omphalocele (HP:0001539) | 1.81236670 |
| 150 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80251241 |
| 151 | Arthropathy (HP:0003040) | 1.79560763 |
| 152 | High anterior hairline (HP:0009890) | 1.79108573 |
| 153 | Poor coordination (HP:0002370) | 1.78432816 |
| 154 | Alacrima (HP:0000522) | 1.77125153 |
| 155 | Optic nerve coloboma (HP:0000588) | 1.76087305 |
| 156 | Meningocele (HP:0002435) | 1.75367145 |
| 157 | Intestinal atresia (HP:0011100) | 1.74138111 |
| 158 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.73485793 |
| 159 | Congenital diaphragmatic hernia (HP:0000776) | 1.71272204 |
| 160 | Nephronophthisis (HP:0000090) | 1.70635284 |
| 161 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70026711 |
| 162 | Deep palmar crease (HP:0006191) | 1.69561127 |
| 163 | Cutaneous syndactyly (HP:0012725) | 1.69287661 |
| 164 | Specific learning disability (HP:0001328) | 1.69099663 |
| 165 | Hypoplastic female external genitalia (HP:0012815) | 1.68970160 |
| 166 | Down-sloping shoulders (HP:0200021) | 1.68686710 |
| 167 | Exotropia (HP:0000577) | 1.68203193 |
| 168 | Chorioretinal coloboma (HP:0000567) | 1.67246260 |
| 169 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.66791592 |
| 170 | Molar tooth sign on MRI (HP:0002419) | 1.66531072 |
| 171 | Abnormality of midbrain morphology (HP:0002418) | 1.66531072 |
| 172 | Abnormality of the pubic bones (HP:0003172) | 1.65877343 |
| 173 | Chronic hepatic failure (HP:0100626) | 1.65652793 |
| 174 | Intellectual disability, moderate (HP:0002342) | 1.65195624 |
| 175 | Esophageal atresia (HP:0002032) | 1.64304406 |
| 176 | Recurrent corneal erosions (HP:0000495) | 1.64071551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.47419866 |
| 2 | CASK | 4.66510265 |
| 3 | STK16 | 3.89165579 |
| 4 | NTRK3 | 3.79778906 |
| 5 | MAP3K9 | 3.41637855 |
| 6 | INSRR | 2.76270737 |
| 7 | KSR2 | 2.67561072 |
| 8 | DAPK2 | 2.56577435 |
| 9 | PRKD3 | 2.53167308 |
| 10 | DYRK2 | 2.40649597 |
| 11 | CAMKK1 | 2.32736465 |
| 12 | RIPK4 | 2.32658067 |
| 13 | NTRK1 | 2.22262369 |
| 14 | MAP3K4 | 2.21571945 |
| 15 | MINK1 | 2.20854569 |
| 16 | ICK | 2.20121287 |
| 17 | CAMK1D | 2.18718537 |
| 18 | FES | 1.97050705 |
| 19 | ARAF | 1.95751831 |
| 20 | NTRK2 | 1.88012654 |
| 21 | PAK6 | 1.82533462 |
| 22 | MARK1 | 1.75118749 |
| 23 | MAP3K13 | 1.73794927 |
| 24 | MATK | 1.72336227 |
| 25 | MAPK15 | 1.62022109 |
| 26 | TAOK1 | 1.57909516 |
| 27 | MAP2K7 | 1.54504231 |
| 28 | CAMKK2 | 1.52244167 |
| 29 | KSR1 | 1.48562529 |
| 30 | * CDK5 | 1.46441290 |
| 31 | EPHB2 | 1.46425274 |
| 32 | TNIK | 1.41009437 |
| 33 | TYRO3 | 1.38060396 |
| 34 | MAP3K2 | 1.37449252 |
| 35 | SIK2 | 1.33850074 |
| 36 | DAPK1 | 1.30021325 |
| 37 | MAP2K4 | 1.29393911 |
| 38 | DYRK1B | 1.28985259 |
| 39 | STK38 | 1.28858856 |
| 40 | PKN2 | 1.25151797 |
| 41 | DYRK3 | 1.21786812 |
| 42 | BCR | 1.21473804 |
| 43 | ERBB2 | 1.16326544 |
| 44 | MAP3K12 | 1.13248685 |
| 45 | PRPF4B | 1.10165807 |
| 46 | PINK1 | 1.08658162 |
| 47 | GRK5 | 1.06864608 |
| 48 | RAF1 | 1.05950318 |
| 49 | NEK1 | 1.05608205 |
| 50 | SGK223 | 1.05054235 |
| 51 | SGK494 | 1.05054235 |
| 52 | LATS2 | 1.04403695 |
| 53 | PRKCH | 1.01471927 |
| 54 | RIPK1 | 0.98395803 |
| 55 | RET | 0.97652240 |
| 56 | CDK15 | 0.94907337 |
| 57 | CDK18 | 0.93583134 |
| 58 | CDK14 | 0.90486870 |
| 59 | DDR2 | 0.90301571 |
| 60 | CAMK2B | 0.90095981 |
| 61 | CAMK2A | 0.89694366 |
| 62 | PRKCG | 0.89686864 |
| 63 | UHMK1 | 0.88203395 |
| 64 | PLK4 | 0.87499803 |
| 65 | MAP3K6 | 0.87452282 |
| 66 | STK11 | 0.87449752 |
| 67 | MAPKAPK5 | 0.87111450 |
| 68 | CSNK1A1L | 0.85987385 |
| 69 | BMPR2 | 0.84928220 |
| 70 | SGK2 | 0.83902510 |
| 71 | CDK11A | 0.83223639 |
| 72 | MARK2 | 0.81705072 |
| 73 | SGK3 | 0.80925157 |
| 74 | MAP3K1 | 0.77403478 |
| 75 | CSNK1G1 | 0.77247247 |
| 76 | CSNK1G2 | 0.76389067 |
| 77 | LMTK2 | 0.76226888 |
| 78 | TNK2 | 0.76141536 |
| 79 | WNK3 | 0.75819055 |
| 80 | CAMK1 | 0.74925249 |
| 81 | SGK1 | 0.74079814 |
| 82 | PHKG2 | 0.73704736 |
| 83 | PHKG1 | 0.73704736 |
| 84 | PDPK1 | 0.71982533 |
| 85 | PRKAA1 | 0.71294454 |
| 86 | PTK2B | 0.70517727 |
| 87 | PDK1 | 0.70289762 |
| 88 | CAMK2D | 0.69848862 |
| 89 | ALK | 0.69588210 |
| 90 | WNK1 | 0.68075359 |
| 91 | PKN1 | 0.65979005 |
| 92 | PNCK | 0.65936777 |
| 93 | MAP3K11 | 0.64934260 |
| 94 | CSNK1E | 0.62948904 |
| 95 | MAPK13 | 0.61263829 |
| 96 | PRKCZ | 0.59597373 |
| 97 | MAP2K1 | 0.59487329 |
| 98 | NME1 | 0.59262399 |
| 99 | CAMK2G | 0.57459678 |
| 100 | RPS6KA3 | 0.55948854 |
| 101 | FYN | 0.55546807 |
| 102 | MUSK | 0.55458768 |
| 103 | NEK6 | 0.54621083 |
| 104 | GRK1 | 0.54604215 |
| 105 | MAP3K7 | 0.53370309 |
| 106 | PRKD2 | 0.52090508 |
| 107 | PLK2 | 0.50901861 |
| 108 | MAPK10 | 0.50500803 |
| 109 | TRIB3 | 0.49346171 |
| 110 | DAPK3 | 0.47899794 |
| 111 | LIMK1 | 0.47290887 |
| 112 | PAK3 | 0.45325754 |
| 113 | BRSK1 | 0.42227388 |
| 114 | CAMK4 | 0.41980377 |
| 115 | MTOR | 0.41274088 |
| 116 | DYRK1A | 0.40957662 |
| 117 | PRKCB | 0.40522191 |
| 118 | MAPK8 | 0.38736696 |
| 119 | BRAF | 0.38057460 |
| 120 | MOS | 0.37761310 |
| 121 | CDC42BPA | 0.37094022 |
| 122 | CAMK1G | 0.36517715 |
| 123 | PRKD1 | 0.36257012 |
| 124 | CSNK1G3 | 0.35792178 |
| 125 | PRKCE | 0.35637417 |
| 126 | SCYL2 | 0.34064524 |
| 127 | FGFR2 | 0.33520732 |
| 128 | PRKG1 | 0.33382766 |
| 129 | PRKACA | 0.33370972 |
| 130 | CSNK1A1 | 0.32516612 |
| 131 | GSK3B | 0.31812945 |
| 132 | PRKACG | 0.31498688 |
| 133 | PTK2 | 0.31030398 |
| 134 | RPS6KA2 | 0.30370307 |
| 135 | WNK4 | 0.30370064 |
| 136 | PRKCA | 0.29546736 |
| 137 | PRKDC | 0.29342659 |
| 138 | STK39 | 0.29036386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 4.14896300 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12020458 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 2.92823824 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.91480743 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85277883 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.84970997 |
| 7 | * Cocaine addiction_Homo sapiens_hsa05030 | 2.82385476 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74040327 |
| 9 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.51994884 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42921678 |
| 11 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.40395845 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38875024 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.33734552 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.04633510 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.99132109 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92538366 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89392410 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.87135803 |
| 19 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.83298639 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81254728 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.77113490 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73001087 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70939737 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68212280 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64955299 |
| 26 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.62199584 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57591050 |
| 28 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.56542459 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47769491 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.46289126 |
| 31 | * Gap junction_Homo sapiens_hsa04540 | 1.42960020 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.40601814 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33252778 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30170461 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28682176 |
| 36 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26166589 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22500594 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.20906742 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20441899 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15556773 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15505429 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.11120496 |
| 43 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.08674461 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05587433 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03527430 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.03206378 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02341237 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01701534 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99712480 |
| 50 | * Alcoholism_Homo sapiens_hsa05034 | 0.99365463 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99099621 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96780782 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95660712 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93928319 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92509711 |
| 56 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.90136122 |
| 57 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87981874 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.87597692 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83696220 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81998818 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81846072 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80755577 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79353331 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76726336 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75801942 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73016963 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.68395261 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68005373 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66247105 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66194943 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65210275 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65141146 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64997147 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61959896 |
| 75 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61526823 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60875655 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60537893 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.58718950 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58650550 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.57051929 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56988004 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56267476 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54998349 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54421440 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53610659 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52923725 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52334339 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49991360 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49526868 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48987077 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48734933 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47829966 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47292717 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45174283 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.44876895 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44447071 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44244459 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44184288 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43990452 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.43569586 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43132418 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42060673 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41060435 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40459273 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.39744177 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38070550 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.37670303 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37491782 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36995544 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36691959 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36439300 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35901542 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35523179 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35371574 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34524087 |
| 116 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32971364 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32104151 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31845704 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31151472 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30730199 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30497149 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30079856 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29419656 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27606584 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24894944 |

